Limited Distribution and Data Capture

Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.

Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.

Bruhn refers to the results of the study "DIMENSIONS of Specialty Pharmaceuticals: Evolving Trends in Market Access," conducted by Avalere Health and commissioned by Janssen Biotech, Inc and Johnson & Johnson Health Care Systems.

For more information, read "Emerging Trends Affecting Market Access to Specialty Therapies" at http://www.specialtypharmacytimes.com/news/Emerging-Trends-Affecting-Market-Access-to-Specialty-Therapies.